1. Home
  2. RDIB vs EMBC Comparison

RDIB vs EMBC Comparison

Compare RDIB & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reading International Inc Class B

RDIB

Reading International Inc Class B

BUY

Current Price

$11.21

Market Cap

263.5M

ML Signal

BUY

Logo Embecta Corp.

EMBC

Embecta Corp.

SELL

Current Price

$6.73

Market Cap

328.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RDIB
EMBC
Founded
1937
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
263.5M
328.1M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
RDIB
EMBC
Price
$11.21
$6.73
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
8.2K
★ 836.9K
Earning Date
11-13-2026
11-24-2026
Dividend Yield
N/A
★ 0.58%
EPS Growth
★ 60.76
20.90
EPS
N/A
★ 1.03
Revenue
★ $202,988,000.00
N/A
Revenue This Year
$15.10
N/A
Revenue Next Year
$4.04
$5.59
P/E Ratio
★ N/A
$6.63
Revenue Growth
N/A
★ N/A
52 Week Low
$8.00
$2.77
52 Week High
$24.00
$14.91

Technical Indicators

Market Signals
Indicator
RDIB
EMBC
Relative Strength Index (RSI) 38.70 67.69
Support Level $10.28 $3.01
Resistance Level $12.59 $9.38
Average True Range (ATR) 0.62 0.28
MACD -0.32 0.05
Stochastic Oscillator 3.78 84.15

Price Performance

Historical Comparison
RDIB
EMBC

About RDIB Reading International Inc Class B

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: